According to public health officials in the United Kingdom, the world’s first ever case of drug resistant gonorrhea, also known as super gonorrhea, has been confirmed. The concern of certain infection becoming resistant to antibiotics has been growing for the past several years in medical professionals. Now, a man in the U.K. has become the first person to be diagnosed with drug resistant gonorrhea.
The patient claims to have had only one sexual partner in the U.K. and one in Southeast Asia about a month before symptoms began to appear. According to reports, the infection did not respond to either azithromycin, an antibiotic frequently used against gonorrhea, or ceftriaxone, which the World Health Organization considers a last-resort treatment for bacterial infections. He was also treated with the antibiotic spectinomycin, the report adds.
Public warnings of this type of infection have been in the news for a long time. In 2013, the CDC reported that there were 246,000 cases of some form of drug-resistant gonorrhea infection world wide. That was 30% of the estimated 820,000 cases that year. Though, these infections were only resistant to the first wave of antibiotics. Even in 2013, the hazard level of this superbug was classified as urgent. The following year, the U.S. government released the “National Strategy for Combating Antibiotic-Resistant Bacteria.” It stated that strains of gonorrhea are developing resistance to current medical treatments.
Gonorrhea can cause a burning or discomfort with urination. It can also cause a genital discharge. It is one of the most common STDs in the United States. Gonorrhea can be passed through anal, oral or vaginal sex. Using protection, such as latex condoms, can greatly reduce your risk of gonorrhea.
If you are concerned that you may have been exposed to gonorrhea, you should get gonorrhea testing performed right away. This can often be the only way to detect an infection.
STD AWARENESS MONTH
All month long GET 20% OFF on a full STD test panel.
Call (888) 768-7064 and speak to one of our Care Advisors